TP53 and gastric cancer: While OXA exerts its influence through p53-mediated transcriptional regulation, ATO modulates nuclear structural dynamics, thereby amplifying apoptotic signaling.39 This comprehensive interaction accentuates the potential of combinatorial therapeutic strategies to overcome resistance mechanisms in gastric cancer.